| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS10048339 | HBV | ENSG00000185803.12 | protein_coding | SLC52A2 | No | No | 79581 | Q9HAB3 |
| TVIS30070373 | HIV | ENSG00000185803.12 | protein_coding | SLC52A2 | No | No | 79581 | Q9HAB3 |
| TVIS30070374 | HIV | ENSG00000185803.12 | protein_coding | SLC52A2 | No | No | 79581 | Q9HAB3 |
| TVIS44013832 | HTLV-1 | ENSG00000185803.12 | protein_coding | SLC52A2 | No | No | 79581 | Q9HAB3 |
| TVIS44005357 | HTLV-1 | ENSG00000185803.12 | protein_coding | SLC52A2 | No | No | 79581 | Q9HAB3 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | SLC52A2 |
|---|---|
| DrugBank ID | DB09072 |
| Drug Name | Sodium oxybate |
| Target ID | BE0004841 |
| UniProt ID | Q9HAB3 |
| Regulation Type | agonist |
| PubMed IDs | 17381187 |
| Citations | Robinson DM, Keating GM: Sodium oxybate: a review of its use in the management of narcolepsy. CNS Drugs. 2007;21(4):337-54. doi: 10.2165/00023210-200721040-00007. |
| Groups | Approved |
| Direct Classification | Short-chain hydroxy acids and derivatives |
| SMILES | [Na+].OCCCC([O-])=O |
| Pathways | |
| PharmGKB | |
| ChEMBL | CHEMBL1200682 |
